The OTC Drug and Dietary Supplement Market was valued at US$ 2,93,255.40 million in 2019and is projected to reach US$ 4,92,102.49 million by 2027; it is expected to grow at a CAGR of 6.8% from 2020 to 2027.
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. However, buying a dietary supplement with medicinal ingredients requires a prescription from a physicianwhen a person is critically ill or requires treatment. These OTC drugs and nutritional supplements have two forms: branded or generic.
The scope of the OTC drug and dietary supplements market includes product, type, form, distribution channel, and region. The market for OTC drug and dietary supplement is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the OTC drug and dietary supplements market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
OTC Drug and Dietary Supplement Market: Strategic Insights
Market Size Value in US$ 2, 93,255.40Million in 2019 Market Size Value by US$ 4, 92,102.49Million by 2027 Growth rate CAGR of 6.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
OTC Drug and Dietary Supplement Market: Strategic Insights
| Market Size Value in | US$ 2, 93,255.40Million in 2019 |
| Market Size Value by | US$ 4, 92,102.49Million by 2027 |
| Growth rate | CAGR of 6.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for OTC Drug and Dietary Supplement Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Awareness Regarding General Health Issues
People nowadays are well aware of general health issues such as cold, cough, allergies, fever, pain, acidity, diarrhea, and skin-related conditions. Major population is focused on having healthy lifestyle by avoiding the consumption of junk food that leads to a rise in lifestyle-related diseases such as diabetes, obesity, and cardiovascular diseases. Growing preference toward maintaining the healthy lifestyle also leads to the consumption of weight-loss products and dietary supplements, such as vitamins, minerals, and supplements. Increase in exposure to the internet has led to greater access to dietary supplements and over the counter (OTC) drugs to consumers, at affordable prices.
The common health issues can be seasonal or they might occur due to minor changes in routine habits; hence, people prefer taking OTC medicines to treat them instead of visiting a doctor. In many cases, this saves time and money, and provides immediate relief. Several governments have initiated various programs toward health awareness, due to which there has been a quick and smooth adoption of everyday technology for healthcare and wellness, contributing to the industry's overall growth. For instance, in India, the government is taking positive steps toward formalizing the use of OTC medicines. Prescription monitoring programs (PMPs) collect, monitor, and analyze electronically transmitted prescribing and dispensing data submitted by pharmacies and dispensing practitioners. This data is then used to prevent OTC drug abuse. Thus, promoting the sale of OTC drugs.
Advancements in the pharmaceutical industry, such as predictive modeling, mobile apps, robotics, and diagnostics, are opening new avenues for pharmacists, which can improve their ability to dispense medication, minimize errors, and monitor patient adherence. Rightly dispensed medicinal product will not result in any type of drug abuse, which further builds confidence of the repurchase of OTC products and dietary supplements. Thus, the awareness of general health concerns and advancements in the pharmaceutical industry are driving market growth.
OTC Drug and Dietary Supplement Product-Based Insights
Based on product, the OTC drug and dietary supplement market is segmented into cough and cold products, vitamins and dietary supplements, analgesics, gastrointestinal products, sleep aids, oral care products, ophthalmic products, antacids, feminine care, and others.
In 2019, the analgesicssegment accounted for the highest share of the market. Growth of this segment is attributed to the growing awareness regarding general health issuesand growing preference for non-prescription drugs over prescription drugs across the world. However, vitamins and dietary supplementssegmentis likely to register the highest CAGR in the global OTC drug and dietary supplementsmarket during the forecast period.
Global OTC Drug and Dietary Supplement Market, by OTC Drug and Dietary Supplement Type– 2019& 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Type-BasedInsights
Based on type, the OTC drug and dietary supplements market is segmented into branded and generic. The genericsegment held a larger share of the market in 2019; whereas, the samesegment is estimated to register a higher CAGR of 7.1% in the market during the forecast period.
Form -Based Insights
Based on form, the OTC drug and dietary supplements market is segmented into tablets, capsules, powders, ointments, liquid, and others. The tabletssegment held the largest share of the market in 2019 and is estimated to register the highest CAGR of 7.5% in the market during the forecast period.
Basedon distribution channel, the OTC drug and dietary supplements market is segmented into hospital and retail pharmacies, retail stores, online channels, and others. The hospital and retail pharmaciessegment held the largest share of the market in 2019;however, the online channelssegment is estimated to register the highest CAGR of 7.5% in the market during the forecast period.
Product launches and expansion strategies are commonly adopted by companies to expand their footprint and product portfolio worldwideas well as tomeet the growing demand.
The market players operating in the OTC drug and dietary supplement market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
By Type
- Branded
- Generic
By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
South America (SAM)
- Brazil
- Argentina
Company Profiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Type ; Form ; Distribution Channel , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The use of OTC drugs to treat various health conditions has allowed saving healthcare expenditure. Also, the consumption of dietary supplements has helped in improving health and enhance immunity. Thus, the products have provided affordable treatment options for both consumers and the healthcare systems across the globe.
The growth of the market is attributed to growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the stringent FDA regulations related to safety and efficacy of OTC drugs is expected to hinder the market growth.
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two forms, such as branded or generic.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 OTC drug and Dietary Supplement– By Product
1.3.2 OTC Drug and Dietary Supplement– By Type
1.3.3 OTC Drug and Dietary Supplement– By Form
1.3.4 OTC Drug and Dietary Supplement – By Distribution Channel
1.3.5 Global OTC Drug and Dietary Supplement– By Geography
2. OTC Drug and Dietary Supplement – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global OTC Drug And Dietary Supplement– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. OTC Drug and Dietary Supplement – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Awareness Regarding General Health Issues
5.1.2 Growing Preference for Non-Prescription Drugs over Prescription Drugs
5.2 Market Restraints
5.2.1 Stringent FDA Regulations Related to Safety and Efficacy of OTC Drugs
5.3 Market Opportunities
5.3.1 R&D Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Selection of OTC Drugs for Minor Diseases
5.5 Impact Analysis
6. OTC Drug and Dietary Supplement – Global Analysis
6.1 Global OTC Drug and Dietary Supplement Revenue Forecast And Analysis
6.2 Global OTC Drug and Dietary Supplement, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. OTC Drug and Dietary Supplement Analysis – By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8. OTC Drug and Dietary Supplement Analysis – By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9. OTC Drug and Dietary Supplement Analysis – By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10. OTC Drug and Dietary Supplement Analysis – By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis
11.1 North America: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 North America: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.4 North America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 North America: OTC Drug and Dietary Supplement Market, By Form – Revenue and Forecast to 2027 (USD Million)
11.1.6 North America: OTC Drug and Dietary Supplement Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 US: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 US: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 US: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 Canada: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Canada: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Canada: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Mexico: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Mexico: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2 Europe: OTC Drug and Dietary Supplement Market
11.2.1 Overview
11.2.2 Europe: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.4 Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.5 Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.6 Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2.7 Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.2.8 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.8.3 Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.8.4 Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.8.5 Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2.9 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.9.1 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.9.2 France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.9.3 France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.9.4 France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.9.5 France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2.10 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.10.1 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.10.2 UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.10.3 UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.10.4 UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2.11 Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Italy: OTC Drug and Dietary Supplement Market,– Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.2.12 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.2.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.2.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.2.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3 Asia-Pacific: OTC Drug and Dietary Supplement Market
11.3.1 Overview
11.3.2 Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.4 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.5 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.6 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3.7 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.3.8 China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.8.3 China: OTC Drug and Dietary Supplement Market,, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.8.4 China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.8.5 China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3.9 Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.9.3 Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.9.4 Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.9.5 Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3.10 India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.10.3 India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.10.4 India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3.11 South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.3.12 Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.3.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.3.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.3.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.4 Middle East & Africa: OTC Drug and Dietary Supplement Market
11.4.1 Overview
11.4.2 Middle East & Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (US$ Million)
11.4.3 Middle East & Africa OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)
11.4.4 Middle East & Africa OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027 (USD Million)
11.4.5 Middle East & Africa OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.4.6 Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.4.7 Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.4.8 Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.4.8.3 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.4.8.4 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.4.8.5 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
11.4.9 UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)
11.4.9.3 UAE: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.4.9.4 UAE: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.4.9.5 UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.4.10 South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.1 South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.4.10.3 South Africa: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.4.10.4 South Africa: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.4.10.5 South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
11.5 South and Central America: OTC Drug and Dietary Supplement Market
11.5.1 Overview
11.5.2 South and Central America: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.5.3 South and Central America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.5.4 South and Central America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.5.5 South and Central America: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.5.6 South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
11.5.7 South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.5.8 Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.5.8.3 Brazil: OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027 (USD Million)
11.5.8.4 Brazil: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.5.8.5 Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.5.9 Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.5.9.3 Argentina: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.5.9.4 Argentina: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
11.5.9.5 Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
12. Impact of COVID-19 Pandemic on Global OTC Drug And Dietary Supplement Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. OTC Drug and Dietary Supplement Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 GlaxoSmithKline plc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 AbbVie Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bausch Health Companies Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bayer AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Procter & Gamble
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Novartis AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Reckitt Benckiser Group Plc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms
LIST OF TABLES
Table 1. North America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: OTC Drug and Dietary Supplement Market, By Form – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: OTC Drug and Dietary Supplement Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. US: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. US: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 8. US: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 24. Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 28. France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 29. UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 30. UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 31. UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 32. UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 33. Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 34. Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 40. Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 41. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 42. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 44. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 45. China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)
Table 46. China: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 47. China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 48. China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 50. Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 52. Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 53. India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 54. India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 55. India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 56. India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 57. South Korea OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 58. South Korea OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 60. South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 61. Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 62. Australia OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 64. Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 65. Middle East & Africa OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 66. Middle East & Africa OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 67. Middle East & Africa OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 68. Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 69. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 70. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
Table 72. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
Table 73. UAE: OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 74. UAE: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 75. UAE: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
Table 76. UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 77. South Africa: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 78. South Africa: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 79. South Africa: OTC Drug and Dietary Supplement Market, by Form– Revenue and Forecast to 2027(USD Million)
Table 80. South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel– Revenue and Forecast to 2027(USD Million)
Table 81. South and Central America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 82. South and Central America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 83. South and Central America: OTC Drug and Dietary Supplement Market, by Form– Revenue and Forecast to 2027(USD Million)
Table 84. South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 85. Brazil: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 86. Brazil: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 87. Brazil: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
Table 88. Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
Table 89. Argentina: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 90. Argentina: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 91. Argentina: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)
Table 92. Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
Table 93. Organic Developments Done By Companies
Table 94. Inorganic Developments Done By Companies
Table 95. Glossary of Terms, OTC Drug and Dietary Supplement
LIST OF FIGURES
Figure 1. OTC Drug and Dietary Supplement Segmentation
Figure 2. OTC Drug and Dietary Supplement– By Geography
Figure 3. OTC Drug and Dietary Supplement Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. OTC Drug and Dietary Supplement, by Geography (US$ Million)
Figure 7. Global OTC Drug and Dietary Supplement – Leading Country Markets (US$ Million)
Figure 8. Global OTC Drug and Dietary Supplement, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
Figure 15. Global OTC Drug and Dietary Supplement – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global OTC Drug and Dietary Supplement – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global OTC Drug and Dietary Supplement
Figure 18. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 19. Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 29. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 30. Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 32. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 33. Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 37. Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 39. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 40. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 41. Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 42. Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 43. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 44. North America: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 45. North America: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 46. North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 47. US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 48. Canada: OTC Drug And Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 49. Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 50. Europe: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 51. Europe: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 52. Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 53. Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 54. France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 55. UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 56. Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 57. Spain: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)
Figure 58. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 59. Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 60. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 61. China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 62. Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Australia: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)
Figure 66. Middle East & Africa: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 67. Middle East & Africa OTC Drug and Dietary Supplement Market –Revenue and Forecast to 2027 (USD Million)
Figure 68. Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 69. Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 70. UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 71. South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 72. South and Central America: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 73. South and Central America OTC Drug and Dietary Supplement Market– Revenue and Forecast to 2027 (USD Million)
Figure 74. South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 75. Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 76. Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 77. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement market in North American Countries
Figure 78. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in European Countries
Figure 79. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Asia Pacific Countries
Figure 80. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Rest of the World
Figure 81. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to OTC Drug and Dietary Supplement Market
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)